Jagdev Sidhu

525 total citations
18 papers, 390 citations indexed

About

Jagdev Sidhu is a scholar working on Immunology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jagdev Sidhu has authored 18 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 4 papers in Genetics and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jagdev Sidhu's work include Immunodeficiency and Autoimmune Disorders (5 papers), Epilepsy research and treatment (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Jagdev Sidhu is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (5 papers), Epilepsy research and treatment (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Jagdev Sidhu collaborates with scholars based in Australia, United States and United Kingdom. Jagdev Sidhu's co-authors include Sarah A. Job, Richard Philipson, Gilles Grollier, A. Segonzac, Frank Larsen, Jonathan M. Edelman, Mikhail Rojavin, Jonathan Bullman, Marc Pfister and John A. Ascher and has published in prestigious journals such as PLoS ONE, Journal of Allergy and Clinical Immunology and Neuropsychopharmacology.

In The Last Decade

Jagdev Sidhu

17 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jagdev Sidhu Australia 10 159 147 87 63 60 18 390
Jens‐Otto Andreas Germany 11 104 0.7× 103 0.7× 105 1.2× 7 0.1× 46 0.8× 18 458
P. J. Miach Australia 12 54 0.3× 54 0.4× 41 0.5× 31 0.5× 21 0.3× 24 571
Maria Laura Sargentini‐Maier Belgium 15 516 3.2× 505 3.4× 15 0.2× 84 1.3× 52 0.9× 21 783
Maren Rohrbacher Germany 11 16 0.1× 103 0.7× 66 0.8× 15 0.2× 37 0.6× 19 482
Lucy Goodman New Zealand 9 53 0.3× 357 2.4× 49 0.6× 13 0.2× 25 0.4× 19 758
Leock Y. Ngo United States 11 126 0.8× 150 1.0× 20 0.2× 8 0.1× 16 0.3× 35 451
Svetlana Dimova Belgium 11 210 1.3× 187 1.3× 19 0.2× 11 0.2× 46 0.8× 34 421
John H. Tyrer Australia 8 160 1.0× 176 1.2× 14 0.2× 24 0.4× 30 0.5× 15 403
Patrick Martin United States 15 175 1.1× 58 0.4× 11 0.1× 12 0.2× 50 0.8× 40 561

Countries citing papers authored by Jagdev Sidhu

Since Specialization
Citations

This map shows the geographic impact of Jagdev Sidhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jagdev Sidhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jagdev Sidhu more than expected).

Fields of papers citing papers by Jagdev Sidhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jagdev Sidhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jagdev Sidhu. The network helps show where Jagdev Sidhu may publish in the future.

Co-authorship network of co-authors of Jagdev Sidhu

This figure shows the co-authorship network connecting the top 25 collaborators of Jagdev Sidhu. A scholar is included among the top collaborators of Jagdev Sidhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jagdev Sidhu. Jagdev Sidhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sidhu, Jagdev, Laura Shaughnessy, Rocío Lledó‐García, et al.. (2024). Population PK modeling of certolizumab pegol in pregnant women with chronic inflammatory diseases. CPT Pharmacometrics & Systems Pharmacology. 13(11). 1904–1914. 1 indexed citations
3.
Pawaskar, Dipti, Michael A. Tortorici, Bruce L. Zuraw, et al.. (2018). Population pharmacokinetics of subcutaneous C1‐inhibitor for prevention of attacks in patients with hereditary angioedema. Clinical & Experimental Allergy. 48(10). 1325–1332. 8 indexed citations
4.
Zhang, Ying, Michael A. Tortorici, Dipti Pawaskar, et al.. (2018). Exposure‐Response Model of Subcutaneous C1‐Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary Angioedema. CPT Pharmacometrics & Systems Pharmacology. 7(3). 158–165. 12 indexed citations
5.
Sidhu, Jagdev, Mikhail Rojavin, Marc Pfister, & Jonathan M. Edelman. (2014). Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodeficiency. PubMed. 4(1-2). 41–55. 25 indexed citations
6.
Sidhu, Jagdev, et al.. (2014). Pharmacokinetic Modeling Predicts Different IgG Exposures Using Different IVIG-Scig Dose Conversion Factors In Patients With Primary Immune Deficiency. Journal of Allergy and Clinical Immunology. 133(2). AB181–AB181. 2 indexed citations
8.
Landersdorfer, Cornelia B., Martin Bexon, Jonathan M. Edelman, et al.. (2013). Pharmacokinetic Modeling and Simulation of Biweekly Subcutaneous Immunoglobulin Dosing in Primary Immunodeficiency. Postgraduate Medicine. 125(6). 53–61. 30 indexed citations
9.
Rojavin, Mikhail, Cornelia B. Landersdorfer, Martin Bexon, Marc Pfister, & Jagdev Sidhu. (2013). Switching From Monthly Intravenous to Biweekly Subcutaneous Immunoglobulin: A Pharmacokinetic Modeling and Simulation Approach. Journal of Allergy and Clinical Immunology. 131(2). AB109–AB109. 1 indexed citations
10.
Bexon, Martin, et al.. (2013). Individuals, Subgroups or Cohorts? A Population Pharmacokinetic Modeling Approach to Optimize Dosing of Hizentra®. Journal of Allergy and Clinical Immunology. 131(2). AB227–AB227. 1 indexed citations
11.
Sidhu, Jagdev, Sarah A. Job, Jonathan Bullman, et al.. (2006). Pharmacokinetics and tolerability of lamotrigine and olanzapine coadministered to healthy subjects. British Journal of Clinical Pharmacology. 61(4). 420–426. 24 indexed citations
12.
Sidhu, Jagdev, et al.. (2005). The pharmacokinetic and pharmacodynamic consequences of the co‐administration of lamotrigine and a combined oral contraceptive in healthy female subjects. British Journal of Clinical Pharmacology. 61(2). 191–199. 117 indexed citations
13.
Theis, Jochen G.W., Jagdev Sidhu, Joanne Palmer, et al.. (2005). Lack of Pharmacokinetic Interaction between Oxcarbazepine and Lamotrigine. Neuropsychopharmacology. 30(12). 2269–2274. 19 indexed citations
14.
Bullman, Jonathan, et al.. (2004). Pharmacokinetic profile of a new form of sumatriptan tablets in healthy volunteers. Current Medical Research and Opinion. 20(6). 803–809. 21 indexed citations
15.
Sidhu, Jagdev & Michael Ashton. (1997). Single-Dose, Comparative Study of Venous, Capillary and Salivary Artemisinin Concentrations in Healthy, Male Adults. American Journal of Tropical Medicine and Hygiene. 56(1). 13–16. 13 indexed citations
16.
Sidhu, Jagdev, et al.. (1997). Steady-state pharmacokinetics of the enantiomers of citalopram and its metabolites in humans. Chirality. 9(7). 686–692. 95 indexed citations
17.
Sidhu, Jagdev, et al.. (1994). Gentamicin Dosing in Elderly Patients Based on Bioelectrical Impedance Analysis. Therapeutic Drug Monitoring. 16(4). 352–360. 2 indexed citations
18.
Sidhu, Jagdev & Bruce Charles. (1993). Simple microscale high-performance liquid chromatographic method for determination of furosemide in neonatal plasma. Journal of Chromatography B Biomedical Sciences and Applications. 612(1). 161–165. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026